drugset / Trial / NCT07579949

A Study of SNH-119014 in Adult Participants With Non-transfusion-dependent Thalassemia (NTDT)

NCT07579949 ↗

Phase 2 Not yet recruiting 30 enrolled ScinnoHub Pharmaceutical Co., Ltd.
RandomizedParallel-groupQuadruple-blindTreatment

Summary

This study is a multicenter study to evaluate the safety, efficacy, pharmacokinetics, and pharmacodynamics of treatment with SNH-119014 in adult participants with non-transfusion-dependent thalassemia. 30 participants with non-transfusion-dependent thalassemia were enrolled.

Timeline

Start
2026-06-18
Primary completion
2027-03-29
Completion
2027-04-29

Drugs

EvaluationDrugModalityDoseRoute
Subject SNH-119014 Small molecule — —

Indications